Cargando…

Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China

BACKGROUND: The aim of this study was to create a screening system for diabetic cardiovascular autonomic neuropathy (DCAN) in diabetic patients. MATERIAL/METHODS: A Chinese cohort of 455 diabetic participants was recruited between 2011 and 2013. Short-term heart rate variability testing was used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Ying, Lv, Yubao, Tang, Zihui, Dong, Jingcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694192/
https://www.ncbi.nlm.nih.gov/pubmed/29125834
http://dx.doi.org/10.12659/MSM.905240
_version_ 1783280090426114048
author Xue, Ying
Lv, Yubao
Tang, Zihui
Dong, Jingcheng
author_facet Xue, Ying
Lv, Yubao
Tang, Zihui
Dong, Jingcheng
author_sort Xue, Ying
collection PubMed
description BACKGROUND: The aim of this study was to create a screening system for diabetic cardiovascular autonomic neuropathy (DCAN) in diabetic patients. MATERIAL/METHODS: A Chinese cohort of 455 diabetic participants was recruited between 2011 and 2013. Short-term heart rate variability testing was used to evaluate cardiovascular autonomic function. A simple model was developed using multiple variable regression to include only significant risk factors that were simple and easily assessed. A DCAN score was determined based on the coefficients of the multiple variable model. This score was tested on the entire cohort of 455 diabetic patients and another independent, external cohort of 115 diabetic patients. RESULTS: The screening system consisted of age, body mass index, duration of diabetes mellitus, and resting heart rate, and these factors were significantly (P<0.05) associated with DCAN. Receiver operating characteristic (ROC) curve analysis was done. The areas under the ROC curve were 0.798, 0.756, and 0.729 for the total sample, validation cohort, and external set, respectively. A cutoff DCAN score of 12 out of 25 produced optimal results for sensitivity (80.36%), specificity (58.27%), and percentage of patients that needed subsequent testing (43.55%) for the validation set. CONCLUSIONS: The study concludes that a simple and practical DCAN screening can be applied for early intervention to delay or prevent the disease in the Chinese population.
format Online
Article
Text
id pubmed-5694192
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-56941922017-11-27 Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China Xue, Ying Lv, Yubao Tang, Zihui Dong, Jingcheng Med Sci Monit Clinical Research BACKGROUND: The aim of this study was to create a screening system for diabetic cardiovascular autonomic neuropathy (DCAN) in diabetic patients. MATERIAL/METHODS: A Chinese cohort of 455 diabetic participants was recruited between 2011 and 2013. Short-term heart rate variability testing was used to evaluate cardiovascular autonomic function. A simple model was developed using multiple variable regression to include only significant risk factors that were simple and easily assessed. A DCAN score was determined based on the coefficients of the multiple variable model. This score was tested on the entire cohort of 455 diabetic patients and another independent, external cohort of 115 diabetic patients. RESULTS: The screening system consisted of age, body mass index, duration of diabetes mellitus, and resting heart rate, and these factors were significantly (P<0.05) associated with DCAN. Receiver operating characteristic (ROC) curve analysis was done. The areas under the ROC curve were 0.798, 0.756, and 0.729 for the total sample, validation cohort, and external set, respectively. A cutoff DCAN score of 12 out of 25 produced optimal results for sensitivity (80.36%), specificity (58.27%), and percentage of patients that needed subsequent testing (43.55%) for the validation set. CONCLUSIONS: The study concludes that a simple and practical DCAN screening can be applied for early intervention to delay or prevent the disease in the Chinese population. International Scientific Literature, Inc. 2017-11-10 /pmc/articles/PMC5694192/ /pubmed/29125834 http://dx.doi.org/10.12659/MSM.905240 Text en © Med Sci Monit, 2017 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Xue, Ying
Lv, Yubao
Tang, Zihui
Dong, Jingcheng
Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China
title Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China
title_full Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China
title_fullStr Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China
title_full_unstemmed Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China
title_short Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China
title_sort analysis of a screening system for diabetic cardiovascular autonomic neuropathy in china
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694192/
https://www.ncbi.nlm.nih.gov/pubmed/29125834
http://dx.doi.org/10.12659/MSM.905240
work_keys_str_mv AT xueying analysisofascreeningsystemfordiabeticcardiovascularautonomicneuropathyinchina
AT lvyubao analysisofascreeningsystemfordiabeticcardiovascularautonomicneuropathyinchina
AT tangzihui analysisofascreeningsystemfordiabeticcardiovascularautonomicneuropathyinchina
AT dongjingcheng analysisofascreeningsystemfordiabeticcardiovascularautonomicneuropathyinchina